Literature DB >> 33057139

BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis.

Ping Li1,2,3, Zhongpei Weng4, Pengfei Li2, Fangyong Hu2, Yan Zhang5, Zijian Guo5, Weibo Shen5, Changyong Zhao6, Saimin Dai7.   

Abstract

Encouraging insight into novel underlying mechanisms targeting abnormal biological pathways in colorectal cancer (CRC) are currently under investigation, edging closer and closer to clinical use. Of note, basic leucine zipper ATF-like transcription factor 3 (BATF3) has been implicated with the tumorigenicity of CRC. The current study aimed to elucidate the oncogenic BATF3-mediated S1PR1/p-STAT3/miR-155-3p/WDR82 axis in CRC. Initially, clinical samples of CRC tissues as well as CRC cell lines were collected to evaluate the expression patterns of BATF3/S1PR1/p-STAT3/miR-155-3p/WDR82. Dual luciferase assay was employed to assess the binding affinity between miR-155-3p and WDR82. Artificial modulation of BATF3 (down- and overexpression) was conducted to measure the malignant phenotypes of CRC cells, while tumor-bearing mice were examined to determine the in vivo effects. BATF3 facilitated the proliferative, migratory, and invasive potential of CRC cells by upregulating S1PR1. Besides, the stimulatory effect of S1PR1 was realized via restored p-STAT3 expression. Furthermore, p-STAT3 was evidenced to heighten the expression of miR-155-3p and subsequently restrict the expression of its target gene WDR82. The in vivo assays provided data further substantiating the in vitro findings that inactivation of the BATF3/S1PR1/p-STAT3/miR-155-3p/WDR82 axis suppresses CRC tumor growth. Collectively, the results of the present study emphasize the oncogenic function of BATF3 illustrated by the reinforcement the biological processes of proliferation, invasion, as well as the metastatic capacity of CRC cells through activating the S1PR1/p-STAT3/miR-155-3p/WDR82 axis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33057139     DOI: 10.1038/s41417-020-00223-2

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  3 in total

1.  Batf3-Dependent Genes Control Tumor Rejection Induced by Dendritic Cells Independently of Cross-Presentation.

Authors:  Derek J Theisen; Stephen T Ferris; Carlos G Briseño; Nicole Kretzer; Arifumi Iwata; Kenneth M Murphy; Theresa L Murphy
Journal:  Cancer Immunol Res       Date:  2018-11-27       Impact factor: 11.151

2.  H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer.

Authors:  He Liu; Yongmin Li; Jingwen Li; Yanlong Liu; Binbin Cui
Journal:  Oncol Lett       Date:  2018-06-05       Impact factor: 2.967

3.  Regulation of miR-155 affects the invasion and migration of gastric carcinoma cells by modulating the STAT3 signaling pathway.

Authors:  Hua Wei; Yan Li; Qiang Ning; Zhi-Min Suo
Journal:  Oncol Lett       Date:  2018-07-16       Impact factor: 2.967

  3 in total
  3 in total

Review 1.  miR-155-3p: processing by-product or rising star in immunity and cancer?

Authors:  Owen Dawson; Anna Maria Piccinini
Journal:  Open Biol       Date:  2022-05-25       Impact factor: 7.124

2.  microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82.

Authors:  Li Song; Bin Luan; Qingrong Xu; Ruihe Shi; Xiufang Wang
Journal:  J Transl Med       Date:  2022-01-04       Impact factor: 5.531

3.  Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer.

Authors:  Xingwu Liu; Guanyu Yan; Boyang Xu; Han Yu; Yue An; Mingjun Sun
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.